UK competition regulator looking into $39 bln AstraZeneca-Alexion deal

Britain’s competition regulator is reviewing AstraZeneca’s (AZN.L) $39 billion buyout of U.S.-based Alexion (ALXN.O) on concerns it could reduce competition in the UK market or elsewhere.

The UK’s Competition and Markets Authority (CMA) said on Tuesday it was inviting comments from any interested party on the deal to help its assessment, setting a deadline of June 3 for any submissions.

Anglo-Swedish drugmaker AstraZeneca, also a major COVID-19 vaccine producer, agreed to buy Alexion in December in its largest ever deal in a bet on rare-disease and immunology drugs and to diversify away from its fast-growing cancer business. read more

Cambridge, UK-based AstraZeneca’s shareholders approved the proposal at a general meeting earlier this month.

The United States has cleared the deal, as have other countries including Canada, Brazil and Russia.

“The commencement of the UK CMA’s formal review is another important step towards closing of the proposed acquisition, which we continue to expect will be in the third quarter of 2021,” a representative for AstraZeneca said.

Alexion did not immediately respond to a request for comment.

It’s best-selling drug Soliris is used against a range of rare immune-disorders including paroxysmal nocturnal hemoglobinuria (PNH), which causes anaemia and blood clots.

AstraZeneca hopes an improved version of the drug has even larger market potential. It expects to boost growth by introducing Alexion’s rare-disease medicines to China and other emerging markets.

Our Standards: The Thomson Reuters Trust Principles.

Source: https://www.reuters.com/world/uk/britain-looking-into-astrazeneca-alexion-deal-competition-concerns-2021-05-25/

World Economic Magazine

Recent Posts

Morgan Stanley Agrees to Buy Vinyl Equity for Shareholder Services

The pending acquisition would add transfer-agent and ownership-record capabilities to Morgan Stanley at Work; the…

1 day ago

Goodyear Installs Roger Wood as Interim CEO During Strategic Review

Mark Stewart exits immediately as the board continues examining the company’s business mix, footprint and…

2 days ago

Securitize Seeks a Lending Foothold With River One Acquisition

The pending deal would connect asset-backed financing with its tokenization business, but market-size figures do…

3 days ago

LKQ Accelerates Sal Abbate’s Arrival as Chief Executive

The automotive-parts supplier ends its interim leadership arrangement more than a month ahead of the…

3 days ago

U.S. and 14 Partners Set Agenda on Manufacturing Excess Capacity

A joint ministerial statement calls for sectoral discussions and an end to market-distorting policies, without…

4 days ago

Aruba Signs Battery Deal to Coordinate Its Power System

Wärtsilä’s 35-megawatt storage project pairs batteries with energy management and maintenance, with takeover expected in…

5 days ago